Company Profile
Perrigo Company PLC Stock Price, News & Analysis
- Ticker:
- PRGO
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- Ireland
Stock performance
12.54 USD (-5.50%)
Close
Last updated: August 6, 2026
1.45B USD
Market cap
Why the stock is moving
Following the latest company update, “Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations”, PRGO closed up 23.1% at $13.27 on Aug 5, 2026. The move occurred in the trading session associated with this earnings update.
Company overview
Consumer Self-Care Portfolio
Perrigo is a global provider of over-the-counter health and wellness products intended for conditions that consumers can prevent or manage themselves. Its portfolio spans branded and store-brand medicines and self-care products sold through major retail and pharmacy channels.
Consumer and Specialty Care Operations
The company serves broad everyday-health categories while also operating a Specialty Care portfolio that includes brands such as Compeed, Opill and ellaOne. Opill gives Perrigo a differentiated presence in women’s health as an over-the-counter daily oral contraceptive in the United States.
Portfolio Simplification
Perrigo is narrowing its focus around core self-care categories and has divested its Dermacosmetics business. The strategy is intended to create a more focused operating structure and concentrate resources on brands and categories where the company has consumer-health scale.
Future catalysts
Perrigo's story is mostly operational and portfolio-driven, with Project Energize and the Dermacosmetics divestiture doing most of the work. The question is whether the business can keep simplifying itself while still extracting value from the self-care and consumer health franchises.
Recent news
- 01
Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations
Source: Perrigo Company PLC
- 02
Perrigo Announces Quarterly Dividend
Source: Perrigo Company PLC
- 03
Perrigo to Present at the Canaccord 46th Annual Growth Conference
Source: Perrigo Company PLC
- 04
Perrigo to Release Second Quarter 2026 Financial Results on August 5, 2026
Source: Perrigo Company PLC
- 05
Perrigo Announces Appointment of Two New Independent Directors to Board
Source: Perrigo Company PLC
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Perrigo Company PLC (PRGO)?
Perrigo Company PLC (PRGO) most recently closed at 12.54 USD, a -5.50% move versus the previous session.
What is the market cap of Perrigo Company PLC (PRGO)?
Perrigo Company PLC currently has a market capitalization of 1.45B USD on BioPharmSignal.
What does Perrigo Company PLC do?
Consumer Self-Care Portfolio Perrigo is a global provider of over-the-counter health and wellness products intended for conditions that consumers can prevent or manage themselves. Its portfolio spans branded and store-brand medicines and self-care products sold through major retail and pharmacy channels. Consumer and Specialty Care Operations The company...
On which exchange is PRGO stock listed?
Perrigo Company PLC (PRGO) is associated with NYSE, Ireland, Biopharma.
What is Consumer?
The question is whether the business can keep simplifying itself while still extracting value from the self-care and consumer health franchises.
Which conditions is Perrigo Company PLC targeting with Consumer?
The question is whether the business can keep simplifying itself while still extracting value from the self-care and consumer health franchises.
How does Perrigo Company PLC describe recent progress with Consumer?
The question is whether the business can keep simplifying itself while still extracting value from the self-care and consumer health franchises.
What is Self-Care?
Consumer Self-Care Portfolio Perrigo is a global provider of over-the-counter health and wellness products intended for conditions that consumers can prevent or manage themselves.